Skip to main content

Security report for dejurepharmacy.co.uk

Other · N/a

Low risk. 3 critical or high findings in SSL/TLS and GDPR outside view.

Security score

79/100

Risk levelLow

0–100, higher is better. How it is calculated

The website represents a premium domain sales page hosted on atom.com, specifically offering the domain dejurepharmacy.co.uk for purchase. The business operates as a domain marketplace, providing verified premium domains with options for installment payments and free transaction support. The site targets domain buyers and investors seeking high-value domain names. Technically, the site employs modern web technologies including Google Tag Manager, Google reCAPTCHA for bot protection, and New Relic for performance monitoring. The site is served over HTTPS with a valid SSL certificate, ensuring secure communications. However, explicit security headers and privacy policies are not evident, indicating room for improvement in compliance and security best practices. The absence of WHOIS data for the atom.com domain introduces some uncertainty regarding domain registration legitimacy, though the site content and branding appear professional and consistent with its business model. Overall, the site presents a moderate security posture with good technical implementation but lacks comprehensive privacy and contact information. Strategic recommendations include adding privacy and cookie policies, implementing security headers, and providing clear contact and incident response details to enhance trust and compliance.

Scanned

NIS2 and GDPR posture

GDPR outside view
73/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

3 findings rated critical or high. Fix these first.

  1. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1
    • High

      Weak SSL Key Length

      SSL certificate uses 256-bit key, which is considered weak

      What to do: Use at least 2048-bit RSA or 256-bit ECC key

      • CWE-326
      • OWASP A04:2025
      • Mozilla TLS: Mozilla Server Side TLS 6.0 intermediate: rsa_key_size 2048

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

Need hands-on remediation? Email guard@offseq.com

Keep watching dejurepharmacy.co.uk

This scan found 14 issues across 5 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
37
Security headers
80
Email security
100
DNS health
85
Network security
100
GDPR outside view
73
Average
79

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Atom.com functions as a premium domain marketplace, focusing on selling verified high-value domains such as dejurepharmacy.co.uk. The business model revolves around domain sales with flexible payment options and transaction support, targeting domain investors and businesses seeking premium online real estate. The market position is that of a specialized reseller with a professional brand presence. The company leverages partnerships with domain registrars and payment processors, though no explicit partner domains were identified in the content. Revenue streams likely include domain sales commissions and installment payment fees. The site content quality and branding consistency support a credible market presence, though the lack of detailed company information and contact data limits deeper business intelligence insights.

Security posture

The website demonstrates a baseline security posture with HTTPS enforced and use of Google reCAPTCHA to mitigate automated abuse. The integration of New Relic indicates active performance and error monitoring. However, the absence of explicit security headers such as Content Security Policy (CSP), HTTP Strict Transport Security (HSTS), and X-Frame-Options reduces defense-in-depth. No vulnerabilities or exposed sensitive data were detected in the analyzed content. The lack of privacy and cookie policies, as well as incident response contact information, indicates compliance gaps, particularly with GDPR and related regulations. The missing WHOIS data for the domain raises moderate trust concerns. Overall, the security posture is adequate but could be significantly improved by adopting recommended best practices and transparency measures.

Recommendations

  1. Implement comprehensive privacy and cookie policies with user consent mechanisms to enhance compliance.
  2. Add security headers including CSP, HSTS, and X-Frame-Options to strengthen site security.
  3. Publish clear contact information and incident response channels to improve trust and readiness.
  4. Regularly audit and update third-party scripts and monitoring tools to mitigate vulnerabilities.
  5. Enhance accessibility features and provide detailed company information to improve user trust and SEO.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Description
dejurepharmacy.co.uk is a verified premium domain available for purchase. Buy now or pay in installments. Free transaction support, no extra fees.
Key services
premium domain sales, installment payment options, transaction support
Content quality
good
Branding
consistent

Technology

Stack
Google Tag Manager, Google reCAPTCHA, New Relic Browser Monitoring, Google Fonts, HTML5, CSS3
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
80/100
Good practices seen
  • HTTPS enforced
  • Google reCAPTCHA for bot protection

Analytics and tracking

Services
Google Tag Manager, New Relic Browser Monitoring
Tracking level
moderate
Privacy practices
poor

Advertising

Tracking pixels
New Relic
Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
moderate

Key observations

  1. Website is accessible and not blocked by WAF or security mechanisms.
  2. WHOIS data for www.atom.com domain is unavailable or not found in the raw WHOIS output.
  3. Site is a premium domain sales page for dejurepharmacy.co.uk hosted on atom.com.
  4. No privacy, cookie, or terms of service policies explicitly found in the HTML content.
  5. No contact emails, phone numbers, or physical addresses explicitly found on the page.
  6. Uses Google Tag Manager and New Relic for analytics and monitoring.
  7. HTTPS is enforced with valid SSL certificate.
  8. No explicit security headers detected in the provided data.
  9. No adult or questionable content detected; site is safe for general audiences.
  10. Site content is professional and consistent with domain marketplace business.
Technical notes

Notes

The website uses a modern technology stack including Google Tag Manager for marketing and analytics, Google reCAPTCHA for bot protection, and New Relic for performance monitoring. Fonts are loaded from Google Fonts with preloading optimizations. The site is served over HTTPS with a valid SSL certificate, ensuring secure data transmission. The HTML and CSS are well-structured with responsive design considerations for mobile optimization. However, no CMS or hosting provider details were identified. Performance is moderate with room for improvement in loading speed and accessibility. The site lacks explicit SEO enhancements beyond basic meta tags. Overall, the technical infrastructure supports a professional domain marketplace but could benefit from additional security and compliance features.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with dejurepharmacy.co.uk. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review dejurepharmacy.co.uk.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.